These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. The treatment of NAFLD. Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594 [TBL] [Abstract][Full Text] [Related]
36. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease. Kadayifci A; Merriman RB Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968 [No Abstract] [Full Text] [Related]
37. The role of metformin in the management of NAFLD. Mazza A; Fruci B; Garinis GA; Giuliano S; Malaguarnera R; Belfiore A Exp Diabetes Res; 2012; 2012():716404. PubMed ID: 22194737 [TBL] [Abstract][Full Text] [Related]
38. Current treatment of non-alcoholic fatty liver disease. Ahmed MH; Byrne CD Diabetes Obes Metab; 2009 Mar; 11(3):188-95. PubMed ID: 18564173 [TBL] [Abstract][Full Text] [Related]
39. [Therapeuric aspects of NAFLD. A literature review]. Tapia NC; Avila FI; Leiva JG; Ramos MH; Avila JF; Uribe M Rev Gastroenterol Mex; 2006; 71(4):487-95. PubMed ID: 17542283 [TBL] [Abstract][Full Text] [Related]
40. [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. Timmer A Z Gastroenterol; 2007 Feb; 45(2):191-3. PubMed ID: 17304406 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]